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Why is it needed? 
Worldwide, women who use drugs are vastly underserved within health and social services and 
programmes1. This is evidenced by the higher HIV and hepatitis C prevalence amongst women 
who inject drugs and driven by the ongoing criminalisation, stigma, and discrimination faced by 
people who use drugs, further compounded by gender inequality and gender-based discrim-
ination2. National and international research, services, guidelines, and training programmes 
are either gender-neutral or male-focused. As harm reduction services are primarily tailored 
to men, women who use drugs often find their specific needs being unacknowledged and 
unaddressed, leading to non gender-responsive harm reduction services. For example, harm 
reduction services and programmes may not guarantee women’s personal safety and confiden-
tiality. In addition, they also may not provide or make referrals to culturally-competent sexual 
and reproductive health services, services for pregnant women, or childcare. Staff in these 
programmes may not be trained to provide adequate support for women who use drugs — 
including for sex workers and transwomen who use drugs — many of whom have experienced 
gender-based violence3. 
What is its purpose? 
The On the A-Gender: Community Monitoring Tool for Gender-Responsive Harm Reduction 
Services for Women who use Drugs aims to be a resource for community advocates to begin 
documenting, evidencing, and addressing this state of play. By doing so, community advocates 
can begin to identify areas and locales where gender-responsive services are severely lacking or 
identify services and programmes that can provide examples of good practice and be scaled up. 
Designed to be primarily used by networks of people who use drugs, the tool is envisaged 
to be most effective when used by peer researchers who have the trust and rapport of the 
community. It is also suitable to be used by programme managers, staff, and other researchers. 
The tool acknowledges the diversity and intersectionality of women who use drugs — including 
sex workers, lesbian and transwomen. 
1  Harm Reduction International. (2018). Women and harm reduction. Retrieved from https://www.hri.global/files/2019/03/06/women-harm-re-
duction-2018.pdf
2 Women and Harm Reduction International Network. (2015). WHRIN submission to OHCHR submission to the 30th session of the Human 
Rights Council (Resolution A/HRC/28/L.22) in regard to the special session of the UN General Assembly on the world drug problem 
(UNGASS) 2016. Retrieved from https://whrin.site/ohchr-submission-to-the-30th-session-of-the-human-rights-council-resolution-a-hrc-28-l-
22-in-regards-to-the-special-session-of-the-un-general-assembly-on-the-world-drug-problem-ungass-2016/
3 Stoicescu, C., Cluver, L., Spreckelsen, T., Casale, M., Sudewo, A., & Irwanto. (2018). Intimate Partner Violence and HIV Sexual Risk 
Behaviour Among Women Who Inject Drugs in Indonesia: A Respondent-Driven Sampling Study. AIDS And Behavior, 22(10), 3307-3323. 
doi: 10.1007/s10461-018-2186-2
4 Transgender is used in this survey to describe persons whose gender identity (their sense of their gender) is different from the sex they 
were assigned at birth. It is not a diagnostic term and is not a medical or psychological condition.
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We hope this resource can be a useful and a practical first step towards developing advocacy 
strategies to introduce and scale up gender-responsive harm reduction services in various settings 
around the world. In this way, the right to health of women who use drugs can be respected and 
better promoted. 
Examples of how the information collected from this survey can be used by community advocates 
to demand better and more inclusive services for women who use drugs include: - 
• Bringing a report of survey results to the attention of Programme Community Committees 
or Advisory Boards  
• Submitting the report of survey results and\or requesting a meeting with Programme 
Managers of local, regional or national Harm Reduction Programmes
• Liaising with the people who use drugs or key population representative on the Global Fund 
Country Coordinating Mechanism (CCM) to highlight gender gaps in programming 
• Submitting the report of survey results and\or requesting a meeting with policymakers and 
other decision-makers in your locale or country 
• Submitting the written report and\or requesting a meeting with donors  
• Presenting the results of the survey at a national or global conference
Where does it come from? 
This tool has been developed by the International Network of People who use Drugs (INPUD) 
and the International Network of Women who use Drugs (INWUD), in collaboration with the 
United Nations Office of Drugs and Crime (UNODC) HIV/AIDS Section and Koalisi Satu Hati , 
a community advocacy group in Indonesia. It is based on the Policy Brief: Women who inject 
Drugs: Addressing Specific Needs (UNODC, UNWomen, WHO, INPUD, 2014) and its companion 
guidelines Addressing the specific needs of women who inject drugs: Practical guide for service 
providers on gender-responsive HIV services (UNODC, INPUD, 2016). 
Data protection and security: Great care must be taken to ensure the confidentiality and security 
of data during the collection, storage and use phase. Benefits of collecting the information must be 
weighed against the risks of data collection. Individuals must give informed consent to the collection, 
storage and use of their personal data. Consent forms should be separated from survey questions and 
kept in safe places. If collected and stored online, data must be securely backed up and password-pro-
tected, and anonymised as much as possible. If collected and stored in paper form, these must be 
locked away in a secure place with access restricted on a need-to-know basis. Unique identifier codes 
should replace personal identifying information. Training on ethics and data safety should be offered 
to those carrying out the research. 
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The purpose of this survey is to assess the current state of gender-responsive harm reduction 
services for people who use drugs, including their accessibility and quality. 
This survey has been developed by the International Network of People who use Drugs (INPUD), 
the International Network of Women who use Drugs (INWUD), in collaboration with Koalisi Satu 
Hati. It is based on normative guidance published by the United Nations Office on Drugs and 
Crime (UNODC) HIV/AIDS Section. 
Your participation in this survey is voluntary. If you decide to not participate in this survey or 
withdraw at any time, it will not pose a problem and it will not affect your access to harm reduction 
or drug treatment services in any way.
The survey involves answering a series of questions that will be asked by a peer interviewer. The 
whole survey will take approximately 35 minutes. Your responses will be confidential, and any 
identifying information such as your name or email address will not be shared with any authori-
ties or the service you are evaluating.  
By participating in this survey, you are providing valuable information to identify challenges in 
harm reduction for women who use drugs. 
If you have any questions, feel free to ask at any point of the survey.
Thank you.
I hereby voluntarily agree to complete this survey to assess gender-responsive harm reduction 
services. I will attempt to answer each question honestly and truthfully. As proof of my assent, I 
am signing this informed consent.
Participant:  ___________________________________________________________________________  
(Nickname or Unique Identifier Code) 
________________________ (Date) ___________________________________________   (Signature)
 
 
Interviewer:  __________________________________________________________________________  
(Complete Name)
________________________ (Date) ___________________________________________   (Signature)
Please rem






Basic information and Demographic Data
1. What is the name of the organisation/clinic/programme being evaluated? 
2. Where is the location of the organisation/clinic/programme? 
3. How old are you?  ________  years old
4. How long have you used drugs?
 < 1 year
 1-5 years
 6 -10 years
 10-15 years
 > 15 years




 Other (please state)  ___________________________________________________________
6. Are you part of a drug user organisation or network? (If yes please name) 
  _________________________________________________________________________________
7. Do you identify as a transgender woman4? 
 Yes 
 No 
4 Transgender is used in this survey to describe persons whose gender identity (their sense of their gender) is different from the sex they 
were assigned at birth. It is not a diagnostic term and is not a medical or psychological condition.
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Your Service Use 
8. Which services do you use at the organisation/clinic/programme you are evaluating? 
Please mark all that apply. 
 Opioid substitution therapy (OST) 
 Needle and syringe programmes (NSPs)
 HIV testing and counselling (HTC)
 Antiretroviral therapy (ART) 
 Treatment of sexually transmitted infections (STI)
 Condom distribution 
 Prevention, vaccination, diagnosis and treatment for viral hepatitis
 Prevention, diagnosis and treatment of tuberculosis
 Naloxone and overdose management 
 Additional services offered: ___________________________________________________
9. When was the last time you visited the organisation/clinic/programme  
you are evaluating?
 This week
 Over a week ago
 Over 2 weeks ago
 Over a month ago
 Over 3 months ago 





10. What are the barriers for you to access harm reduction services? (multiple answers 
allowed)
 Lack of cost for transportation to the organisation/clinic/programme
 Concerns for your own personal safety (e.g. possibility of police arrest or violence)
 Cost of services are too expensive for you
 Service hours do not suit you 
 Concerns about your information being shared with authorities or being outed as 
a drug user in your local community 
 Limited services are available 
 Bad attitude of healthcare workers (discriminating behaviour towards you)
 You are too busy with work
 No childcare is offered at the organisation/clinic/programme
 Partners or family are against you visiting the organisation/clinic/programme 
 Rules and regulation of the organisation/clinic/programme are too strict 











Gender-sensitive Services Offered 
11. Does the organisation/clinic/programme offer the following?
Access and availability  Yes No Don’t know If yes, does it  
     sufficiently meet 
     needs? 
Outreach specifically for women    
Outreach specifically for  
transwomen    
Service is easy to access  
(e.g. short travel time)     
Service is discreetly located  
(respects confidentiality)     
Includes women-friendly hours5     
Provides childcare     
Provides women-only waiting  
areas and/or women-only times    
Low-threshold service  
e.g. no appointments needed,  
short waiting times etc.    
Provides additional commodities,  
services or activities (e.g. showers,  
nutritional support etc.)    
Drop-in centre with  
women-only hours     
Runs women-only peer  
support groups     
Runs transwomen-only peer  
support groups 
 




5 This means that harm reduction services are open at times that match the schedules and needs of women who are working or have 
childcare and/or other responsibilities. Decisions on opening hours are best made after consulting with women who use drugs. 
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12. Are the following additional services integrated into the organisation/clinic/
programme, or are there effective referral or linkage processes in place?  
Additional services 
Couples support for harm 
reduction (for equal sharing of 
responsibility for reducing health 
and social harms between both 
partners)  
Legal advice and support  
Counselling or mental  
health support  
Advice and support for pregnant 
women (including for PMTCT)  
Sexual health services  (e.g. 
prevention and treatment of STI’s)
Family planning  
(e.g. contraception) 
Gender-based violence services 
and programmes (specific legal 
support, sexual assault kits, 
counselling and safety strategies)8  
Safe houses/shelters for women 
and transwomen in abusive and 
violent situations  
Educational/employment  
opportunities   
Seminars/workshops on health, 
gender-based violence etc.  
Drug consumption room 
















6 Integration in this context means that the additional service is being provided at the same physical location as the organisation/clinic/
programme being evaluated. 
7 Linkages to other services means that the organisation/clinic/programme follows up on referrals to additional services in order to facilitate 
and support your enrolment and attendance in other services and programmes. 
8 For the purposes of this document, gender-based violence refers to physical, mental, emotional and other forms of abuse and harassment 




13. Do the staff at the organisation/clinic/programme meet the following:
Staffing considerations Yes, definitely Yes, mostly  Sometimes No, not at all
Does it appear the staff  
have been trained on 
women’s needs?
Does it appear the staff 
have been trained on 
transwomen’s needs?
Do the staff make all 
women feel welcome and 
safe?
Is there a good ratio of 
female-to-male staff?
Can service users request  
to only see female staff?
Do the staff have a 
non-judgmental attitude 
towards women who 
use drugs? 
Do the staff have a 
non-judgmental attitude 
towards transwomen  
who use drugs? 
Do women work across all 
levels of the service e.g. 
are there female doctors? 
Are there any comments you’d like to add about staff attitude and approach or anything else 




14. Does the organisation/clinic/programme you’re evaluating involve the community of 
people who use drugs in the following ways?
Community involvement Yes,  Yes,   Sometimes No, not Don’t 
  definitely mostly  at all know
Women who use drugs are engaged  
in stages of planning, implementation, 
and monitoring  
Transwomen who use drugs are 
engaged in stages of planning, 
implementation and monitoring  
Women who use drugs are paid 
employees or employed as peer 
outreach workers 
Transwomen who use drugs are  
paid employees or employed as  
peer outreach workers 
Women who use drugs hold positions  
in the management structure  
Transwomen who use drugs hold 
positions in the management structure 
Policies of the organisation are relevant 
for staff who use drugs and protective  
of their safety and human rights 
Community can bring issues and 
solutions to the attention of the 
service-provider through processes 
and mechanisms e.g. a community 
committee  
Women in all their diversity are 
comfortable and feel welcome
Are there any comments you’d like to add about how well the organisation/clinic/programme 





You have now completed all questions. Thank you for your time and contribution to this 
survey which will be used to help advocate for better access and quality of harm reduction 
services for women in all their diversity.
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